Delivery Order SPE2DB22D3010-SPE2DB25FP3NT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Valganciclovir 450 mg tablets in quantities of 60 units, with a ceiling value of $12,058.08. This non-set-aside, firm fixed-price delivery order is scheduled for completion by July 21, 2025, with fulfillment performed from AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Valganciclovir HCL 50 mg/ml in an 88ml unit, valued at $3,439.80 under firm fixed pricing. This delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Valganciclovir HCl 50 mg/ml in an 88 ml formulation, with a contract ceiling value of $8,470.02 and an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $4,120.32 to AmerisourceBergen Drug Corp for the supply of Valganciclovir HCL 50 mg/ml in an 88ml formulation. This is a firm fixed price, non-set-aside delivery order with a completion date of September 11, 2025, issued on September 10, 2025. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,507.63, is for the delivery of 60 tablets of the medication Valganciclovir 450 mg. The contract has a firm fixed price and an ultimate completion date of November 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Valganciclovir 450 mg tablets (60-count packages) under a firm fixed-price contract valued at $4,031.70. This non-set-aside award was issued on June 18, 2025, with an ultimate completion date of June 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valganciclovir is an antiviral medication used to treat cytomegalovirus...
- This federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of Valganciclovir 450 mg Tablets in 60-count packages. The $1,235.97 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 60 units of the prescription drug Valganciclovir 450 mg tablets. The contract has a completion date of January 3, 2024 and a potential value of $1,857.32. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from...
- The Defense Logistics Agency awarded a $11,387.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Valganciclovir 450 mg, an antiviral medication commonly used to treat cytomegalovirus infections in immunocompromised patients. This non-set-aside competitive award was issued on August 22, 2025, with an ultimate completion date of August 25, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply contract vehicle. The...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,158,577 units of Valganciclovir 450 mg tablets in 60-count packages, with a ceiling value of $3,526.68. It is a firm fixed-price delivery order contract with a performance period ending on May 7, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB25FP3NTDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Valganciclovir 450 mg tablets (60-count) under a firm fixed-price contract valued at $1,081.86. This is a non-set-aside competitive award with an ultimate completion date of September 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this delivery order as a child contract under its larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This delivery order represents a routine pharmaceutical supply requirement under AmerisourceBergen's comprehensive $999,999,999.00 IDC (designated SPE2DX) that runs through December 2026. The parent contract serves as a global pharmaceutical support vehicle enabling the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Through this flexible contract mechanism, AmerisourceBergen continues to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems with specialized pharmaceutical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/18/25 |